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We reported elsewhere that an untranslated CTG expansion causes the dominantly inherited neurodegenerative
disorder spinocerebellar ataxia type 8 (SCA8). SCA8 shows a complex inheritance pattern with extremes of in-
complete penetrance, in which often only one or two affected individuals are found in a given family. SCA8
expansions have also been found in control chromosomes, indicating that separate genetic or environmental factors
increase disease penetrance among SCA8-expansion–carrying patients with ataxia. We describe themolecular genetic
features and disease penetrance of 37 different families with SCA8 ataxia from the United States, Canada, Japan,
and Mexico. Haplotype analysis using 17 STR markers spanning an ∼1-Mb region was performed on the families
with ataxia, on a group of expansion carriers in the general population, and on psychiatric patients, to clarify the
genetic basis of the reduced penetrance and to investigate whether CTG expansions among different populations
share a common ancestral background. Two major ancestrally related haplotypes (A and A′) were found among
white families with ataxia, normal controls, and patients with major psychosis, indicating a common ancestral
origin of both pathogenic and nonpathogenic SCA8 expansions among whites. Two additional and distinct hap-
lotypes were found among a group of Japanese families with ataxia (haplotype B) and a Mexican family with
ataxia (haplotype C). Our ﬁnding that SCA8 expansions on three independently arising haplotypes are found among
patients with ataxia and cosegregate with ataxia when multiple family members are affected further supports the
direct role of the CTG expansion in disease pathogenesis.
Introduction
Repeat-expansion mutations cause 17 inherited neuro-
logical disorders, including fragile-X syndrome (MIM
309550), myotonic dystrophy types 1 and 2 (DM1
[MIM 160900] and DM2 [MIM 602668]), Huntington
disease (MIM 143100), and 9 forms of spinocerebellar
ataxia (SCAs) (Warren 1996; Zoghbi and Orr 2000;
Ranum and Day 2002). Initially, it was thought that
expansion mutations caused disease either by decreasing
gene expression, as in the case of fragile-X syndrome
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(Jin and Warren 2000), or by altering the protein coding
portion of the gene product, as in the majority of known
SCA mutations caused by CAG trinucleotide expansions
encoding elongated polyglutamine tracts (Orr 2001). Re-
cently, a growing number of inherited neurological dis-
eases have been shown to be caused by expansions that
are transcribed into RNA but not translated into protein,
including SCA8 (MIM 603680), SCA10 (MIM603516),
SCA12 (MIM 604326), DM1, DM2, and FXTAS (MIM
309550) (Holmes et al. 1999, 2001; Koob et al. 1999;
Matsuura et al. 2000; Hagerman et al. 2001; Liquori et
al. 2001; Jacquemont et al. 2003).
SCA type 8 (SCA8) is an inherited neurodegenerative
disorder caused by a CTG trinucleotide repeat expan-
sion in a noncoding gene of unknown function. Using
our RAPID cloning method, we isolated the SCA8 CTG
expansion directly from the DNA of a single patient
with ataxia (Koob et al. 1998, 1999). Unlike positional
cloning approaches, RAPID cloning does not require
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Figure 1 Histograms of the combined CTA/CTG repeat sizes in SCA8 expansion chromosomes of families with ataxia, normal controls,
and patients with major psychosis. A vertical bar shows an allele with the CTG expansion. A, Histograms of alleles with the expanded repeats
(174) in affected patients and unaffected carriers from the MN-A family and from other small families with SCA8. The number of expanded
alleles in each group is shown. The carrier with 143 repeats (marked by an asterisk [*]) is clinically unaffected; however, signiﬁcant cerebellar
atrophy was seen on MRI. B, Histograms of expanded repeats in chromosomes of normal controls and patients with major psychosis.
prior linkage data, large pedigrees, or highly penetrant
inheritance patterns. The SCA8 expansion was found
subsequently in additional families with ataxia, includ-
ing the seven-generation MN-A family that we de-
scribed elsewhere (Koob et al. 1999; Day et al. 2000).
Affected individuals show slowly progressive, relatively
pure cerebellar symptoms such as gait and limb ataxia,
ataxic dysarthria, and nystagmus, with variable ages at
onset. The CTG expansion is unusual because it was
the ﬁrst untranslated repeat expansion thought to cause
ataxia by a gain-of-function RNA mechanism and be-
cause it shows dramatic genetic instability and reduced
disease penetrance (Koob et al. 1999; Day et al. 2000;
Ikeda et al. 2000; Moseley et al. 2000a, 2000b; Cellini
et al. 2002; Topisirovic et al. 2002). Surprisingly, SCA8
expansions have also been found on control chromo-
somes, leading to the suggestion that the SCA8 ex-
pansion in our MN-A family, reported elsewhere
( , ) (Koob et al. 1999; Day et al.LODp 6.8 vp .0
2000), may be in linkage disequilibrium with a neigh-
boring disease-causing mutation and that the expansion
is a coincidental background ﬁnding in the other fam-
ilies with ataxia and SCA8 expansions (Juvonen et al.
2000; Moseley et al. 2000a; Stevanin et al. 2000; Vin-
cent et al. 2000a, 2000b; Worth et al. 2000; Sobrido et
al. 2001; Izumi et al. 2003; Schols et al. 2003). To clarify
the genetics of SCA8, we performed molecular genetic
comparisons of a large number of SCA8 expansion car-
riers, including the large MN-A family and 36 smaller
families with ataxia that are SCA8 positive. Haplotype
analysis was performed to determine if the expansions
on ataxia chromosomes arose independently of expan-
sions on control chromosomes and to examine whether
a mutation in cis could cause ataxia or modify SCA8
disease penetrance.
Material and Methods
Study Subjects
We identiﬁed 37 families with SCA8 ataxia: 32 fam-
ilies are white and live in the United States or Canada
(31 of European and 1 of Central Asian descent), 4 fam-
ilies are from Japan, and 1 family is from Mexico. We
obtained informed consent, performed neurological ex-
ams, and collected blood samples from 245 individuals,
including affected patients ( ) and their relatives.np 63
Also analyzed were 13 SCA8-expansion–positive
DNA samples sent to Athena Diagnostics for ataxia test-
ing. These samples had no clinical or family identiﬁers
and may include both patients with ataxia as well as
unaffected individuals sent for diagnostic testing. In ad-
dition, we studied 7 unrelated and apparently unaffected
individuals (including members of CEPH families 1334
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and 1416) and 14 patients, reported elsewhere, with
major psychosis and SCA8 expansions (Day et al. 2000;
Vincent et al. 2000b). In these two groups without
ataxia, 74 combined CTA/CTG repeats (74 is the
smallest expansion number found in a patient with
ataxia) is the threshold for inclusion in the study. The
term “reduced penetrance” that is used throughout this
article refers to the lack of clinical symptoms of ataxia
among unaffected expansion carriers with affected rel-
atives and among expansion carriers in the general pop-
ulation with no family history of ataxia.
Genetic Analysis
Genomic DNA was isolated from venous blood, with
the use of Puregene kit #D-5000 (Gentra Systems). The
number of combined CTA/CTG repeats at the SCA8
locus was determined by PCR, as described elsewhere
(Koob et al. 1999). Subjects who appeared homozygous
by PCR were screened subsequently by Southern blot
analysis to detect expansions too large to be ampliﬁed.
The combined CTA/CTG repeat lengths of very large
expansions were estimated by Southern blot analysis.
The number of CTA repeats preceding the CTG expan-
sion was determined by sequence analysis in 13 families,
as described elsewhere (Moseley et al. 2000b).
An AﬂII polymorphism located 90 bp 3′ of the CTG
repeat expansion was discovered in the MN-A family
by sequence analysis; it was assayed subsequently by
performing the SCA8 PCR (described above) and sub-
jecting the PCR products to AﬂII digestion (New Eng-
land Biolabs). Products containing the AﬂII polymor-
phism fail to digest.
Development of STR Markers in the SCA8 Region
Di-, tri-, tetra-, and penta-nucleotide repeats exceed-
ing 8 units were identiﬁed and developed as candidate
polymorphic markers on the basis of the sequence in-
formation available from the UCSC genome browser
and NCBI databases (Genome Database). PCR primers
ﬂanking STR sequences were designed with the use of
Primer3. The 5′ end of each forward primer was labeled
with [g-33P] ATP by T4 polynucleotide kinase (NewEng-
land Biolabs). PCR reactions were as follows: 20–50 ng
of genomic DNA was mixed in a 5.5-ml reaction mixture
containing 2 pmol of each primer, 10 mM of Tris-HCl
(pH 9.0), 50 mM of KCl, 0.1% Triton X-100, 0.01%
(weight/volume) gelatin, 200 mM of deoxynucleotide
triphosphates, and 0.1 U of AmpliTaq DNA polymerase
(Applied Biosystems), with variable concentrations of
MgCl2 for each marker (see table A1 [online only]). For
all markers except D13S318, the PCR reaction was de-
natured at 94C for 3 min, followed by 35 cycles (94C
for 45 s, 51C/54C/57C for 45 s, 72C for 60 s) with
a ﬁnal extension at 72C for 6 min. For D13S318, the
PCR reaction was denatured at 94C for 3 min, followed
by 35 cycles (94C for 45 s, 55C for 75 s, 72C for 75
s) with a ﬁnal extension at 72C for 6 min. PCR primers,
as well as speciﬁc annealing temperatures and MgCl2
concentrations, are described in table A1 (online only).
The PCR products were run on 4% denaturing poly-
acrylamide gels at 65 watts and were visualized by au-
toradiography. Allele sizes for each marker are given in
bp and were determined by comparison with an M13
sequencing ladder.
SCA8 expansion haplotypes were established by de-
termining which allele cosegregated with the SCA8 ex-
pansion in each family. The haplotypes of 38 control
chromosomes were constructed by determining the al-
leles that were passed from unrelated spouses to their
offspring. In the event that the associated allele for a
marker could not be determined unequivocally, both al-
leles are given.
Haplotypes are presented from centromere to telo-
mere, on the basis of the map position of the markers,
as follows: D13S275-YI18-YI17-YI15-D13S318-YI14-
CL2-D13S1296-CL4-CL6-(CTG)n-CL8-CL1-JJ9-JJ10-
JJ12-JJ11-D13S135. Alleles are designated by their size
in bp; the SCA8 combined CTA/CTG repeats and iso-
lated CTA repeat tracts are given by the number of re-
peats. Allele frequencies for each microsatellite marker,
calculated from the genotypes of 82 unrelated SCA8-
negative control chromosomes, are shown in table 1.
Statistical Analysis
Statistical differences in repeat size among the various
clinical groups with SCA8 expansions were calculated
by Student’s t-test (one-tailed). Comparisons of the fre-
quencies of SCA8 expansions in controls with those in
patient groups were performed by x2 analysis. Analysis
of the segregation of the SCA8 expansion among ad-
ditional affected members (excluding affected probands)
of the families with ataxia was performed by x2 analysis.
Linkage analysis on the small families with ataxia was
performed by LINKAGE (v5.1) (Weeks et al. 1995), as
described elsewhere (Koob et al. 1999), with the mod-
iﬁcation that the asymptomatic carriers were assigned a
liability class with an expected penetrance of 10%.
Results
Size of Pathogenic and Nonpathogenic SCA8
Expansions
Figure 1 shows the size distributions of SCA8 expan-
sions found in panels of families with ataxia, psychiatric
patients, and controls. The repeat sizes found in affected
members of a large family with SCA8 ataxia (MN-A;
, ) are compared with unaffectedMN-LODp 6.8 vp .0
A family members that also carry the SCA8 expansion
Table 1
Allele Frequencies of STR Markers
Marker and
Allele (bp)
Frequency
(%)
D13S275 ( ):np 78
188 2.6
186 2.6
184 30.8
182 62.7
172 1.3
YI18 ( ):np 78
246 1.3
242 2.6
238 1.3
234 3.8
222 3.8
218 12.8
214 27.0
210 17.9
206 20.6
202 3.8
194 1.3
190 3.8
YI17 ( ):np 76
263 11.8
258 3.9
253 15.8
248 40.9
243 25.0
238 2.6
YI15 ( ):np 72
236 12.5
235 1.4
233 9.7
232 4.2
230 44.5
227 8.3
224 19.4
D13S318 ( ):np 80
296 1.3
292 1.3
288 10.0
284 20.0
280 21.3
276 27.3
272 13.8
268 5.0
YI14 ( ):np 82
172 2.4
170 13.4
168 14.6
166 1.2
164 37.9
162 30.5
CL2 ( ):np 78
203 15.4
200 44.8
197 37.2
194 2.6
(continued)
Table 1 (continued)
Marker and
Allele (bp)
Frequency
(%)
D13S1296 ( ):np 80
193 2.5
191 1.3
189 5.0
187 6.3
185 10.0
183 28.6
181 22.3
179 10.0
177 6.3
175 3.8
173 1.3
167 1.3
165 1.3
CL4 ( ):np 80
173 1.3
169 15.0
168 7.5
167 25.0
165 2.5
164 1.3
163 20.0
158 2.5
157 24.9
CL6 ( ):np 80
151 2.5
149 28.8
147 36.1
145 31.3
141 1.3
CL8 ( ):np 82
248 1.2
247 4.9
246 18.3
245 31.7
244 23.2
243 20.7
CL1 ( ):np 78
168 2.6
166 3.8
164 12.8
160 15.4
158 11.5
156 47.5
148 6.4
JJ9 ( ):np 80
202 2.5
200 20.0
199 8.8
198 6.3
196 61.1
194 1.3
JJ10 ( ):np 80
251 18.8
249 17.5
247 62.4
245 1.3
(continued)
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Table 1 (continued)
Marker and
Allele (bp)
Frequency
(%)
JJ12 ( ):np 78
176 1.3
174 6.4
172 11.5
170 3.8
168 9.0
166 3.8
164 7.7
162 56.5
JJ11 ( ):np 80
212 2.5
210 7.5
208 5.0
206 16.3
204 51.1
202 11.3
198 6.3
D13S135 ( ):np 82
190 11.0
188 6.1
186 14.6
184 7.3
182 44.0
180 8.5
178 8.5
(ﬁg. 1A). Affected MN-A family members have signif-
icantly ( ) larger expansions (110–127,9Pp 5# 10
mean 119) than unaffected MN-A expansion carriers
(73–104, mean 90), with the exception of a clinically
unaffected 42-year-old individual with 143 repeats
whose cerebellum is atrophic on MRI (indicated by an
asterisk [*] in ﬁg. 1A) (Day et al. 2003). Although all
individuals in the MN-A family with 1110 repeats show
signs of ataxia or cerebellar atrophy, expansion carriers
with !110 repeats in the MN-A family (21/35) have
shown no signs of ataxia. The tight correlation between
repeat size and pathogenesis found in the MN-A family
is not found in the broader panel of families with SCA8
ataxia (ﬁg. 1A). The reduced penetrance, which appears
to be inﬂuenced by repeat size for the MN-A family, is
much more pronounced in other families with SCA8
ataxia, regardless of repeat length. Among all 37 ex-
amined families with ataxia, SCA8 sizes among affected
and unaffected expansion carriers can be shorter or
longer than the pathogenic threshold found in the MN-
A family. These data demonstrate that SCA8 expansions
found among patients with ataxia vary dramatically in
size and that the presence of an SCA8 expansion cannot
be used to predict whether or not an asymptomatic in-
dividual will develop ataxia.
SCA8 Expansions in Controls
SCA8 expansions were also found in control samples,
including two CEPH families (1334 and 1416). Among
2,626 unrelated control chromosomes analyzed in Min-
nesota and Canada, we identiﬁed 10 SCA8 alleles
(0.4%) containing 174 combined CTA/CTG repeats (ﬁg.
1B). One of the control expansions was from a grand-
mother of CEPH family 1416. Medical histories indicate
that neither this woman nor her son (54 years old, 800
repeats) are affected by ataxia. All six of the SCA8 ex-
pansion carriers in this family (ﬁg. 2G) were asymptom-
atic at the time of clinical evaluation. The expansion-
positive individuals in generation III were children when
they were evaluated clinically, and, thus, it is not clear
if they will be at higher risk of developing ataxia.
Expansions containing 174 combined repeats oc-
curred on 12 (4%) of 292 independent chromosomes in
our original collection of probands from genetically un-
deﬁned families with ataxia. Although the frequency of
expansions with 174 combined repeats is signiﬁcantly
higher among unrelated probands with ataxia than in
the general population (10/2,626 chromosomes; Pp
), the relative frequency of alleles with 174254# 10
combined repeats in the general population appears to
occur at a higher frequency than all forms of ataxia (∼1/
10,000). Taken together, these data suggest that the CTG
repeat can cause ataxia but that environmental or genetic
modiﬁers, including repeat length, affect disease pene-
trance. SCA8 alleles with 174 repeats among patients di-
agnosed with major psychosis, which were reported else-
where, are also shown (Vincent et al. 2000a) (ﬁg. 1B).
Reduced Penetrance in Families with SCA8 Expansions
SCA8 is transmitted in an autosomal dominant pat-
tern with reduced penetrance in the MN-A family, with
one copy of the mutation found in affected individuals.
In other families, SCA8 shows a complex inheritance
pattern in which only a subset of expansion carriers from
a given family are affected. Representative pedigrees in-
cluded in this study are shown in ﬁgure 2. The families
shown in ﬁgure 2A and 2B appear to transmit ataxia in
a dominant pattern with affected individuals in multiple
generations. In ﬁgure 2C and 2D, multiple affected in-
dividuals were found in a single generation, whereas the
families represented in ﬁgure 2E and 2F have only single
affected individuals.
In contrast to the relatively large number of affected
patients in the MN-A family ( ), 25 of the re-np 13
maining 36 families with ataxia had only a single af-
fected individual, 9 families had two affected individu-
als, and only 2 families had three affected individuals.
Although only a subset of the expansion carriers in the
MN-A family develop ataxia (13/35), these data illus-
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Figure 2 SCA8 pedigrees with varying degrees of disease pen-
etrance. The pedigrees have been altered to preserve conﬁdentiality.
Symbols for individuals affected by ataxia are blackened, and unaf-
fected expansion carriers are indicated by symbols with a dot inside
them. A diagonal line through a symbol denotes an individual who is
deceased. The numbers of the combined CTA/CTG repeat tracts for
the expanded and unexpanded alleles are shown below the symbol.
Representative pedigrees show affected individuals in multiple gen-
erations of a branch of the C1 (MN-A) (pedigree A) and C14 (pedigree
B) families, affected individuals in a single generation of the C24 (ped-
igree C) and C9 (pedigree D) families, single affected individuals in
the C23 (pedigree E) and C12 (pedigree F) families, and no affected
individuals in the CEPH1416 family (pedigree G). Individuals indi-
cated with an asterisk (*) are negative for CTG expansion by Southern
analysis. Reduced penetrance is observed in all of these families.
trate that the penetrance of ataxia appears to be signif-
icantly higher in the MN-A pedigree than in the group
of 36 smaller families with ataxia that are included in
our study.
SCA8 Expansions Cosegregate with Ataxia in Small
Families
In the MN-A family, other studies have shown that
the cosegregation of the SCA8 expansion and ataxia is
highly signiﬁcant ( , ). To distinguishLODp 6.8 vp .00
the possibility that the SCA8 expansions are found sim-
ply by chance in the 36 additional smaller families with
ataxia from the possibility that the expansions do in fact
predispose carriers to ataxia, we examined the incidence
of the expansion cosegregating with ataxia in family
members other than the probands. If, for example, the
expansion did not predispose patients to ataxia but was
found merely by chance in these 36 families, then we
would expect that a 50% frequency of the SCA8 ex-
pansion would be found in additional affected ﬁrst-
degree relatives. In contrast, 12 of the 13 affected ﬁrst-
degree relatives available for analysis also inherited the
SCA8 expansion, indicating that the expansion cosegre-
gates with ataxia in these small families ( ).Pp .0038
The only exception was found in a family (C10, ﬁg. 3A)
in which two sisters were affected with a form of ataxia
clinically distinct from SCA8 by being a markedly more
severe disease with rapid disease progression, pro-
nounced choreiform movements, a severe sensory
neuronopathy, and neuromyotonic discharges seen by
electromyography. Because the striking phenotypic
distinctions suggest that a separate disease is segregating
in the C10 family, the family was excluded from further
analysis. Linkage analysis was performed on the re-
maining small families with multiple affected individu-
als. Table 2 shows the results of the linkage analysis of
these 10 families with ataxia. Although the highest LOD
score for a single family is only 0.34 at a recombination
fraction (v) of .00, the LOD scores were consistently
positive and, when combined, exceeded the threshold
level of 2.0, considered signiﬁcant for testing linkage of
an X-linked disorder or linkage to a single speciﬁc locus
(Ott 1991). The cosegregation of the SCA8 expansion
among additional affected relatives in the group of small
families with ataxia indicates that the SCA8 expansion
directly predisposes individuals to developing ataxia.
Haplotype Analysis of SCA8 Expansions
To better understand the origin of the SCA8 expansion
and the reduced penetrance of the disease, we performed
haplotype analysis on a panel of 37 families with SCA8
ataxia, 13 SCA8-expansion–positive samples that were
sent to Athena Diagnostics for ataxia testing, 7 control
samples with expansions, and 14 expansion carrierswith
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Table 2
Linkage Analysis of SCA8 Expansion and Ataxia in Small Families
LOD SCORE AT v p
FAMILY HAPLOTYPE .00 .01 .05 .10 .20 .30 .40
C2 A .34 .33 .29 .25 .16 .08 .03
C3 A .30 .29 .26 .21 .13 .06 .02
C9 A .15 .15 .13 .11 .07 .03 .01
C11 A .29 .28 .27 .25 .20 .15 .08
C13 A and B .26 .25 .22 .19 .11 .05 .01
C14 A .02 .02 .02 .02 .02 .01 .01
C19 A′ .30 .29 .26 .21 .13 .06 .02
C24 A′ .29 .28 .25 .21 .13 .06 .02
J1 B .00 .00 .00 .00 .00 .00 .00
J2 B .07 .07 .05 .04 .02 .01 .00
All 2.02 1.96 1.75 1.49 .95 .51 .20
psychiatric diseases. A total of 17 polymorphic STR
markers were analyzed, including 13 newly developed
markers that span a region of ∼1 Mb ﬂanking the SCA8
CTG repeat. Figure 4 shows the location of the STR
markers relative to the SCA8 CTG-repeat tract and the
genomic organization of the SCA8 gene and the over-
lapping Kelch Like 1 (KLHL1) gene.
SCA8 Expansions in Whites Arose from a Common
Founder
The majority of SCA8 expansion families, in the
groups with and without ataxia, are white. Most of the
chromosomes carrying SCA8 expansions in white fam-
ilies with ataxia, in Athena samples, in psychiatric pa-
tients, and in control subjects have haplotype A or A′
(ﬁg. 3A). The core haplotype region deﬁned by 10 con-
secutive markers ﬂanking the CTG repeat (YI17-YI15-
D13S318-YI14-CL2-D13S1296-CL4-CL6-(CTG)exp-
CL8-CL1) is nearly identical on haplotypes A and A′,
with differences at the D13S1296 and YI15 markers
likely explained by microsatellite instability. The differ-
ences in the ﬂanking regions of haplotype A and A′ are
likely to have resulted from ancestral recombination
events at markers YI18 and JJ9, located 284 kb cen-
tromeric and 17 kb telomeric from the CTG repeat,
respectively. Possible ancestral recombination and in-
stability events accounting for the various related hap-
lotypes are diagrammed in ﬁgure 3B. The haplotype data
demonstrate that the majority of SCA8 expansions in
white families with and without ataxia arose from a
common ancestral mutation, and that these families
share a region of ∼290 kb ﬂanking the SCA8 CTG repeat
tract. As in other white families, the Central Asian family
with SCA8 ataxia (C17; see ﬁg. 3A) carried haplotype
A with minor variations at two outer markers.
Two Additional Haplotypes Found Among Japanese
and Mexican Families with Ataxia
Four unrelated Japanese families with ataxia have an
SCA8 expansion haplotype (B) distinct from the two
predominant haplotypes in whites (J1–J4; see ﬁg. 3A).
Two chromosomes from whites with ataxia (family C32
and the C13B chromosome of a patient homozygous for
SCA8) have haplotypes similar to haplotype B, with var-
iations likely the result of recombination events at mark-
ers ﬂanking the CTG expansion. A third distinct hap-
lotype (C) was found in a Mexican family with ataxia
(M1; see ﬁg. 3A). These results indicate that indepen-
dently arising SCA8 expansions are found in families of
various ethnic backgrounds who are affected by ataxia.
SCA8 Expansion Haplotypes Relatively Rare in the
General Population
To determine if the SCA8 expansion haplotypes were
common in the general population, 38 control chro-
mosomes were screened with the use of four consecutive
markers ﬂanking the CTG repeat (CL4-CL6-(CTG)n-
CL8-CL1). A total of 26 distinct haplotypes containing
these four core markers were found. The most common
haplotype, found on ﬁve chromosomes (13.2%), was
167-145-(CTG)n-244-156. None of the control chro-
mosomes had haplotypes identical to the core region
identiﬁed in the major ataxia haplotypes A and A′ in
whites (165-147-(CTG)n-246-156). Two control chro-
mosomes (5.3%) had the same core region of haplotype
B (168-145-(CTG)n-245-160), and no chromosomes had
the same core region of haplotype C.
Clinical Features of Families with SCA8 with Different
Haplotypes
The clinical features of the families with SCA8
(grouped by haplotype) are shown in table 3. No obvious
phenotypic differences are noted between haplotype
groups. The clinical features of the MN-A family (hap-
lotype A, ﬁg. 3A) are shown separately because of the
large number of affected subjects. Regardless of hap-
lotype group, patients with SCA8 ataxia are character-
ized by high frequencies of gait ataxia, ataxic dysarthria,
limb dysmetria, and gaze-evoked nystagmus, indicating
pancerebellar involvement. Pyramidal tract signs and re-
duced vibratory sense are observed less frequently.Other
neurological signs are rare or absent. The clinical fea-
tures of the families with SCA8 can be summarized as
relatively pure cerebellar ataxia. The disease progression
is typically very slow, even when onset of ataxia was
during the 1st decade of life. When available, MRI scans
invariably showed pancerebellar atrophy without brain-
stem or cerebral atrophy.
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Figure 3 Results of haplotype analyses. A, Haplotype analysis of several SCA8-expansion–positive families with and without ataxia. The
markers in this ﬁgure are shown in order of their physical distance from the CTG repeat. Group I, Haplotypes of 37 SCA8-positive families
in which at least one member has been diagnosed with ataxia. Two predominant and probably related SCA8 expansion haplotypes (A and A′)
were found in 18 and 13 families, respectively. Six families, including four from Japan, have a clearly distinct second haplotype (B), and a
Mexican family shows evidence for a third independent haplotype (C). The consensus haplotype A is shown in yellow. Minor deviations in
repeat size of1 repeat unit ﬂanked by markers with conserved allele sizes are indicated by alternative colors (color key at bottom). Recombinant
11
regions that are not conserved among families are shown in white. Two families (C13 and C26) presented with homozygous expansion-positive
patients, and the separate SCA8 haplotypes for these families are indicated. The microsatellite marker name, its repeat motif, and its distance
from the SCA8 CTG repeat expansion are shown (top). The size range of the combined CTA/CTG repeat expansions in the family (or, in some
cases, in a single expansion carrier) are shown. Group II, SCA8 expansion haplotypes of 13 samples sent to Athena Diagnostics for testing are
either haplotype A or A′, except for a single subject (AD13) with haplotype B. Group III, Haplotypes of seven normal control families, including
two CEPH families, with SCA8 expansions. Four of these families had haplotype A, three had haplotype A′. Group IV, Haplotypes of 14
patients with major psychosis and CTG expansions are either haplotype A ( ) or haplotype A′ ( ). B, Proposed ancestral origin ofnp 8 np 6
SCA8 haplotypes. Proposed ancestral relationship between the major haplotype variants is shown by a small number of ancestral recombination
and microsatellite instability events.
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Figure 4 Map of newly developed polymorphic markers in the SCA8 region. Genomic DNA is represented by a horizontal line, and
double slashes (//) represent regions in which the map is not drawn to scale. Of the 17 microsatellite markers that were genotyped, 13 were
newly developed. The markers and their relative map positions are indicated with their distance from the SCA8 CTG repeat given in kb. Six
exons and the promoter region of the SCA8 gene and exons 1, 5, and 11 of the KLHL1 gene are indicated by boxes. The CTG repeat exists
in exon A of the SCA8 gene. SCA8 transcript is transcribed in antisense orientation to KLHL1 transcription through exon 1 of KLHL1. Internal
scale bar is indicated as 20 kb.
Variations on the MN-A and Other SCA8 Haplotypes
To further investigate possible differences in the MN-
A haplotype that may account for the relatively high
penetrance found in that family, we analyzed haplotype
differences and sequence variations that occurred in the
MN-A family but not in the other families with SCA8
ataxia. In theMN-A family (C1; see ﬁg. 3A), consecutive
allele variations in ﬁve markers from D13S318 to
D13S275 suggest that the haplotype in theMN-A family
diverged from haplotype A through an ancestral recom-
bination event between the D13S318 and YI14 markers.
This recombination event may have resulted in a cis-
modiﬁer that increases disease penetrance being juxta-
posed to the SCA8 expansion. Although similar but sep-
arate recombination events also occurred on several
other chromosomes with haplotypes A′ and B (C26B,
C30, C31, C32, and C13B), these events did not appear
to increase disease penetrance and would be unlikely to
have introduced a similar linked modiﬁer. Although our
haplotype data indicate that the expansion chromo-
somes in whites arose from a single or small number of
founder chromosomes, signiﬁcant size variation of the
CTA repeat that ﬂanks the CTG expansion is found on
haplotype A, with repeats ranging from 3–17 CTAs (ta-
ble 4). The CTA portion of the repeat tract has been
reported elsewhere to be stable within individual fami-
lies, and, therefore, the CTA repeat numbers listed in
table 4 are likely to be the same within individual fam-
ilies (Moseley et al. 2000b). The CTA repeat tract in the
MN-A family is much smaller than that in any of the
other families with SCA8 ataxia that we analyzed and,
hence, is another notable genetic difference.
Further evidence that the region immediately ﬂanking
the CTG expansion is highly mutable comes from the
identiﬁcation of an SNP that was found in the MN-A
family but not in 17 other families with haplotype A or
A′ that were tested. This SNP is located 90 bp imme-
diately 3′ of the CTG expansion and is well within the
region of haplotype A conservation. It is possible that—
but not yet clear whether—these differences play a role
in the increased disease penetrance of the MN-A family.
A summary of the sequence variations ﬂanking the SCA8
CTG expansion is shown in table 4.
Possible Role of Unexpanded Allele as Genetic
Modiﬁer of Disease Penetrance
To examine the possibility that the second predispos-
ing factor could involve the unexpanded SCA8 alleles,
we examined the subset of families with affected sib pairs
to determine if, in addition to the SCA8 expansion, they
also inherited the same unexpanded allele from the sec-
ond parent. All ﬁve sib pairs available for analysis shared
the same unexpanded SCA8 allele, showing a marginally
signiﬁcant result ( ).Pp .025
Homozygous Expansion Carriers
Five patients from three different families with ataxia
were homozygous for the SCA8 expansion with 174
CTA/CTG repeats. Two of these patients were reported
elsewhere as members of a consanguineous branch of
the MN-A family. The other homozygous patients were
members of families C13 and C26. The C13 family has
haplotypes A and B, whereas the C26 homozygote has
one consensus haplotype A′ with the second chromo-
some carrying a version of haplotype A′ with a divergent
centromeric end likely representing a recombination
event (C26A and C26B, respectively). Clinical infor-
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Table 3
Clinical Features of SCA8 Families with Different Haplotypes
% AFFECTED IN HAPLOTYPE GROUP (Abnl/n)a
CLINICAL FEATURE MN-A Family Haplotype Ab Haplotype A′ Haplotype B All
Gait ataxia 91 (10/11) 92 (11/12) 75 (3/4) 100 (7/7) 91 (31/34)
Limb ataxia 91 (10/11) 86 (18/21) 100 (5/5) 100 (6/6) 91 (39/43)
Dysarthria 100 (11/11) 85 (17/20) 100 (4/4) 100 (7/7) 93 (39/42)
Impaired smooth pursuit 73 (8/11) 76 (19/25) 67 (4/6) 100 (7/7) 78 (38/49)
Nystagmus 73 (8/11) 72 (13/18) 83 (5/6) 71 (5/7) 74 (31/42)
Reduced vibratory sense 45 (5/11) 45 (9/20) 0 (0/6) 33 (2/6) 37 (16/43)
Hyperreﬂexia 73 (8/11) 40 (8/20) 67 (4/6) 29 (2/7) 50 (22/44)
Hyporeﬂexia 0 (0/11) 15 (3/20) 0 (0/6) 14 (1/7) 9 (4/44)
Extensor plantar response 18 (2/11) 15 (2/13) 40 (2/5) 0 (0/7) 17 (6/36)
Muscle atrophy 0 (0/11) 8 (1/12) 20 (1/5) 0 (0/7) 6 (2/35)
a Abln/n p no. of abnormal individuals/no. of patients with ataxia that were examined.
b MN-A family not included.
mation for three of the ﬁve homozygous subjects was
available and, in each of these cases, the disease symp-
toms and the clinical course of the disease were similar
to affected individuals with a single SCA8 expansion.
Discussion
We reported elsewhere that an untranslated CTG ex-
pansion causes SCA8. Although age-dependent reduced
penetrance is found in all microsatellite-expansion dis-
orders, the age-independent reduced penetrance of SCA8
is the most difﬁcult genetic feature of the disease to un-
derstand. To investigate potential causes of reduced pen-
etrance, we compared the molecular genetic features of
37 different families with SCA8 that were from the
United States, Canada, Japan, andMexico. To determine
the role that the expansion and cis-acting factors play
in predisposing patients to ataxia, high-resolution hap-
lotype analysis was performed on the families with
ataxia, as well as on a group of expansion carriers in
the general population and on psychiatric patients.
High-resolution haplotypes were established by typing
17 microsatellite markers, including 13 new markers we
developed that span an ∼1-Mb region ﬂanking the SCA8
CTG expansion.
In contrast to other studies with markers 3.2 Mb and
1 Mb centromeric and 0.9 Mb and 1.8 Mb telomeric
from the CTG expansion (Koob et al. 1999; Juvonen
et al. 2000) that did not show obvious haplotype con-
servation, the results of our high-resolution haplotype
analyses (ﬁg. 3A) show two predominant conserved
haplotypes (A and A′) among white families with SCA8
ataxia. The core haplotype region deﬁned by the 10
consecutive markers ﬂanking the CTG repeat (YI17-
YI15-D13S318-YI14-CL2-D13S1296-CL4-CL6-
[CTG]exp-CL8-CL1) is nearly identical on haplotypes
A and A′, with differences at the D13S1296 and YI15
markers likely caused by microsatellite instability. In
addition, a distinct haplotype (haplotype B) is conserved
among four Japanese and twowhite families with ataxia
(C32 and C13B), and a third haplotype (haplotype C)
is found in a Mexican family with ataxia. These results
demonstrate that at least three independently arising
SCA8 expansions are associated with ataxia.
Interestingly, subjects from Athena Diagnostics with
CTG expansions (whom we presume were tested be-
cause of clinical ataxia, but about whom we have no
clinical information), normal controls (including two
CEPH families), and patients with major psychosis have
the same haplotypes (A and A′) found in white families
with ataxia, except for a single subject (AD13) from
Athena Diagnostics who shows haplotype B. These re-
sults indicate that, among whites, CTG expansions in
normal controls and patients with major psychosis have
the same ancestral origin as the families with SCA8
ataxia. The reason that these expansion-positive con-
trols and patients with major psychosis do not exhibit
ataxia is not yet understood.
Evidence that the expansion itself predisposes families
to ataxia, independent of cis-acting modiﬁers includes:
(1) the high frequency of ataxia among SCA8 expansion
carriers versus controls ( ); (2) the com-25Pp 4# 10
mon clinical phenotype among affected families; (3) the
cosegregation of the expansion and ataxia in small fam-
ilies with multiple affected individuals, excluding the
MN-A family ( ); and (4) a LOD score of 6.8Pp .0038
at in the MN-A family and a combined LODvp .00
score of 2.02 at among 10 small families withvp .00
multiple affected individuals. Because the SCA8 expan-
sion was isolated from a single patient with ataxia by
our RAPID cloning method (Koob et al. 1998, 1999)
instead of a positional cloning approach that depends
on large families, it is not surprising that the genetic
characteristics and disease penetrance do not follow the
pattern of SCAs deﬁned elsewhere.
The penetrance of the SCA8 expansion ismuch higher
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Table 4
Highly Mutable Sequences Flanking the SCA8 CTG
Expansion
Haplotype,
Ethnic Origin,
and Family
No. of CTA
Repeatsa
No. of CTG
Repeats G/A SNPa,b
A, white:
C1 (MN-A) 3 70∼140 G
C2 8 72∼80 A
C3 8 72∼107 A
C8 17 54∼71 A
C9 ND 208∼750c A
C10 12 118∼723 A
C11 9 92∼109 A
C12 12 78∼131 A
C13A ND 97∼120c A
C14 12 81∼114 A
C15 ND 91c A
C16 ND 169c A
C22 ND 845∼945c A
C23 ND 130∼1,110c A
A′, white:
C24 9 168∼254 A
C26A/B ND 101∼950c A
C29 ND 75c A
C30 ND 150c A
B, Japanese:
J1 9 80∼96 ND
J2 8 87∼91 ND
J3 8 147 ND
J4 8 87∼128 ND
B, white:
C13B ND 97∼120c A
C, Mexican:
M1 ND 100c ND
a ND p not determined.
b G/A SNP identiﬁed 90 bp 3′ of the CTG expansion in the
MN-A family.
c Number of CTA repeats is unknown; therefore, values
represent the combined number of CTA/CTG repeats.
in the MN-A family than in the other families with
ataxia that we describe here or that have been reported
elsewhere in the literature (Mosemiller et al. 2003). In
contrast to the relatively large number of affected pa-
tients in the MN-A family ( ), 25 (∼70%) of thenp 13
small families with ataxia in our study had only a single
affected individual, 9 families had two, and only 2 fam-
ilies had three. Although the expansion in the MN-A
family arose from the same founder as the other white
families with an SCA8 expansion of haplotype A, sev-
eral genetic differences between the MN-A family and
the small families with ataxia may contribute to the
increased disease penetrance in the MN-A family.
First, the affected chromosome in the MN-A family
(C1) has haplotype A, with a superimposed centromer-
ic recombination event that occurred between the
D13S318 and YI14 markers. It is possible that this re-
combination event, which occurred 112–137 kb 5′ of
the CTG repeat or ∼70 kb upstream of the suggested
promoter region of SCA8 (Benzow and Koob 2002),
could account for the relatively high disease penetrance
in the MN-A family. Although it appears that this re-
combination event would be too far upstream to act as
an enhancer for the currently deﬁned promoter, it is
possible that alternative upstream promoter elements
have not yet been identiﬁed and that the presence of
this alternative chromosomal region 5′ of the SCA8 tran-
script could increase SCA8 transcriptional activity. Al-
tered SCA8 expression may increase the toxic effects of
the resultant CUG-containing transcripts, resulting in
the relatively high penetrance of the disease in the MN-
A family. Substantial evidence supporting a model of
RNA pathogenesis has accumulated in the myotonic
dystrophy ﬁeld, in which dominant effects of CUG and
CCUG repeat-containing transcripts have been shown
to be the primary diseasemechanism (Philips et al. 1998;
Mankodi et al. 2000; Tapscott 2000; Liquori et al.
2001; Tapscott and Thornton 2001; Kanadia et al.
2003). A similar disease mechanism may be responsible
for SCA8. Alternatively, the recombinant chromosomal
region could harbor other genetic modiﬁers, including
those of the overlappingKLHL1 gene (Koob et al. 1999;
Nemes et al. 2000).
Additional genetic variations in theMN-A family that
are present within the conserved portion of the haplo-
type A include: the SNP located 90 bp 3′ of the CTG,
the relatively short CTA repeat tract containing only 3
repeats, and interruptions within the CTG portion of
the repeat (Moseley et al. 2000b). It is not yet clear
whether the 5′ recombination event, or the other se-
quence variations we have identiﬁed, increase disease
penetrance in the MN-A family. However, the sequence
variations we have observed, in addition to changes in
overall repeat length, indicate that both the CTG repeat
tract and the region immediately ﬂanking the CTG ex-
pansion are highly mutable.
In addition to possible cis-modiﬁers that our haplo-
type results suggest play a role in increasing disease
penetrance in the MN-A family, we have examined the
possible involvement of the unexpanded SCA8 allele as
a trans-modiﬁer in the other families with SCA8.
Among ﬁve available affected sib pairs, all ﬁve inherited
the same unexpanded allele from the other parent
( ). This result suggests the possibility that aPp .025
subset of SCA8 alleles not containing the expansionmay
increase the likelihood that the disease will be expressed.
On review of the literature, we found six additional sib
pairs with complete genotype results for the unex-
panded SCA8 allele (Juvonen et al. 2000; Silveira et al.
2000; Brusco et al. 2002; Schols et al. 2003). Four of
these sib pairs share the same unexpanded allele, and
two do not (not signiﬁcant), if combined with our data
. Additional data will be needed to determinePp .034
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whether or not this suggestive trend is found in a larger
group of patients.
The reduced penetrance commonly seen in families
with SCA8 could be the result of modifying genetic fac-
tors similar to those reported in other diseases, including
amyotrophic lateral sclerosis (ALS). In familial ALS1
(MIM 105400), identical point mutations within the
SOD1 gene result in remarkable variation in disease
onset within and between families. Recently,VEGFwas
shown to act as a genetic modiﬁer in patients with spo-
radic and familial ALS (Lambrechts et al. 2003). Ho-
mozygous variations in the VEGF promoter reduce cir-
culating VEGF levels and increase the risk of developing
ALS (Lambrechts et al. 2003). Similarly, a clariﬁcation
of modiﬁers in degenerative ataxias could help us to
understand the reduced penetrance of SCA8.
The data presented here provide additional pieces of
a complex puzzle, by describing in detail the repeat
ranges found in various SCA8 expansion populations.
Furthermore, although not all expansions cause ataxia,
in families in which multiple members are affected, the
expansion cosegregates with the disease in the addi-
tional affected relatives ( ). Although the ma-Pp .0038
jority of the families were too small for linkage analysis,
the combined LOD score for all of the clinically similar
families with multiple affected individuals was con-
sistent with the SCA8 expansion causing disease
( ). In addition, our haplotype and se-LODp 2.02
quence analyses have uncovered several genetic varia-
tions in the MN-A family that may play a role in in-
creasing disease penetrance in that family. Finally, the
discovery that SCA8 expansions among patients with
ataxia arose independently on three different haplotypes
suggests that independently arising SCA8 expansions
can cause ataxia. Although this additional information
helps clarify the genetic complexities of ataxia, further
analysis in cell culture and animal models will be needed
to understand the molecular mechanisms involved in
SCA8 and the reasons for the reduced penetrance.
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